Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;38(3):219-226.
doi: 10.5146/tjpath.2021.01564.

Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease

Affiliations

Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease

Ceren Hangul et al. Turk Patoloji Derg. 2022.

Abstract

Objective: DUX4 is an embryonic transcription factor (TF) later silenced in somatic tissues, while active in germline testis cells. Re-expression in somatic cells has been revealed to be present in pathologic conditions such as dystrophy, leukemia, and other cancer types. Embryonic cells, cancer cells and testis cells that show DUX4 expression are pluri-multipotent cells. This lead us to question "Could DUX4 be a TF that is active in certain types of potent somatic cells?" As a perfect reflection of the potent cell pool, we aimed to reveal DUX4 expression in the bone marrow.

Material and method: Bone marrow aspiration materials of seven healthy donors aged between 3 and 32 (2 males/5 females) were investigated with qPCR analysis after RNA isolation for the presence of DUX4 full length mRNA expression. Samples have been investigated for protein existence of DUX4 via immunohistochemistry in two donors that had sufficient aspiration material.

Results: DUX4 mRNA expression was present in all donors, with higher expression compared to B-actin. DUX4 positive stained cells were also detected by immunohistochemistry.

Conclusion: With these results, novel expression for DUX4 in hematopoietic tissue is described. Further studies on the function of DUX4 in hematopoietic cells can shed light on DUX4-related pathways, and contribute to the treatment of DUX4-related diseases such as B-ALL, other cancers, and facioscapulohumeral muscular dystrophy.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
A) qPCR analysis of seven healthy donors with different ages and gender. Blue bars represent DUX4 mRNA expression and grey bars represent housekeeping B-actin mRNA expression. B) DeltaCT values of DUX-fl mRNA expression in bone marrow aspirates.
Figure 2
Figure 2
DUX4 Immunohistochemistry figures of bone marrow aspirates of Donor 2. A) Red arrows indicate brown cells that are positive for DUX4 protein, blue arrows indicate DUX4 negative cells. B) Red arrows indicate DUX4 positive cells, blue arrows indicate DUX4 negative cells, black arrow indicates DUX4 positive cell with its huge nucleus. All photographs have been taken 20X microscopic magnification.
Figure 3
Figure 3
DUX4 Immunohistochemistry figures of bone marrow aspirates of Donor 3. A) Red arrows indicate brown cells that are positive for DUX4 protein, blue arrows indicate DUX4 negative cells. B) Black arrow indicates DUX4 positive huge cell with an empty cytoplasmic area around, indicating a megakaryocyte. All photographs have been taken 20X microscopic magnification.
*Asterisks indicate additional hypothesis that is suggested for the role of DUX4. DUX4-fl; full length, DUX4r; DUX4 re-arrangement/fusion.
Figure 4
Schematic presentation for the DUX4 role in (A) healthy hematopoietic cells, healthy embryonic cells, healthy skeletal differentiation and FSHD; (B) in malignancy. Revealed knowledge referred with authors.

Similar articles

References

    1. Campbell Amy E., Belleville Andrea E., Resnick Rebecca, Shadle Sean C., Tapscott Stephen J. Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle. Aug;2018 Hum Mol Genet. 27:R153–R162. doi: 10.1093/hmg/ddy162. - DOI - PMC - PubMed
    1. De Iaco Alberto, Planet Evarist, Coluccio Andrea, Verp Sonia, Duc Julien, Trono Didier. DUX-family transcription factors regulate zygotic genome activation in placental mammals. Jun;2017 Nat Genet. 49:941–945. doi: 10.1038/ng.3858. - DOI - PMC - PubMed
    1. Hendrickson Peter G., Doráis Jessie A., Grow Edward J., Whiddon Jennifer L., Lim Jong-Won, Wike Candice L., Weaver Bradley D., Pflueger Christian, Emery Benjamin R., Wilcox Aaron L., Nix David A., Peterson C. Matthew, Tapscott Stephen J., Carrell Douglas T., Cairns Bradley R. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons. Jun;2017 Nat Genet. 49:925–934. doi: 10.1038/ng.3844. - DOI - PMC - PubMed
    1. Gabriëls J., Beckers M. C., Ding H., De Vriese A., Plaisance S., Maarel S. M., Padberg G. W., Frants R. R., Hewitt J. E., Collen D., Belayew A. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Aug;1999 Gene. 236:25–32. doi: 10.1016/s0378-1119(99)00267-x. - DOI - PubMed
    1. Deutekom J. C., Wijmenga C., Tienhoven E. A., Gruter A. M., Hewitt J. E., Padberg G. W., Ommen G. J., Hofker M. H., Frants R. R. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Dec;1993 Hum Mol Genet. 2:2037–2042. doi: 10.1093/hmg/2.12.2037. - DOI - PubMed